La Pitié Salpêtrière Hospital
Welcome,         Profile    Billing    Logout  
 17 Trials 
8 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Duval, Xavier
FAVIDOSE, NCT06024421: Evaluation of Tolerance and Pharmacokinetic Profile of High Doses of Favipiravir in Healthy Volunteers

Recruiting
1
39
Europe
favipiravir, Placebo
Institut National de la Santé Et de la Recherche Médicale, France, FUJIFILM Toyama Chemical Co., Ltd.
Infectious Disease, Pharmacology
06/27
11/27
RESPIVAC, NCT05582239: Measure of Vaccine Effectiveness to Prevent Hospitalizations for Viral Respiratory Infections in Adults

Recruiting
N/A
2400
Europe
ANRS, Emerging Infectious Diseases, P95, I-REIVAC, EPICONCEPT, Institut de Recherche en Santé Publique, France
Severe Acute Respiratory Infection (SARI), Influenza, COVID-19
01/26
01/26
Ratziu, Vlad
NATiV3, NCT04849728: A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( )

Recruiting
3
1000
Europe, Canada, US, RoW
IVA337, Lanifibranor, Placebo
Inventiva Pharma
NASH - Nonalcoholic Steatohepatitis
09/25
09/26
B-Well 2, NCT05630820 / 2022-002268-53: Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B

Active, not recruiting
3
871
Europe, Canada, Japan, US, RoW
Bepirovirsen, Placebo
GlaxoSmithKline, GlaxoSmithKline Research & Development Limited
Chronic Hepatitis B, Hepatitis B, Chronic
11/25
05/26
HORIZON, NCT05583344 / 2022-002538-14: Phase 2b Study of GSK4532990 in Adults With NASH

Active, not recruiting
2
284
Europe, Canada, Japan, US, RoW
GSK4532990, Placebo
GlaxoSmithKline, GlaxoSmithKline Research & Development Limited
Nonalcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease
01/26
04/27
M148, NCT06519331: Development of a New Method for Liver Stiffness Measurement Using FibroScan

Not yet recruiting
N/A
114
Europe
Research FibroScan (FS)
Echosens
Liver Diseases
10/26
05/27
DPAILO-1, NCT06344364: Digital Pathology and AI for Liver Outcomes in MASLD

Not yet recruiting
N/A
1800
Europe, RoW
Digital Pathology FibroNest Phenotypic Fibrosis Composite Score (Ph-FCS)
PharmaNest, Inc, Chinese University of Hong Kong, University of Edinburgh, University of Seville, Imperial College London, Icahn School of Medicine at Mount Sinai, Fundacio Clinic Barcelona, Sorbonne University, Newcastle University
Metabolic Dysfunction-associated Steatotic Liver Disease
05/25
07/25
NCT05479721: LITMUS Imaging Study

Active, not recruiting
N/A
450
Europe, US
University of Oxford, Newcastle University, University of Nottingham, University of Cambridge, University of Seville, Pinnacle Clinical Research, PLLC, ICAN Nutrition Education and Research, Assistance Publique - Hôpitaux de Paris, University of Angers, University of Palermo, University of Turin, Italy, University Medical Center Mainz, University of Helsinki, University of Bern, Linkoeping University, Perspectum, Antaros Medical, Resoundant Inc, Pfizer, Novartis, Takeda, Intercept Pharmaceuticals, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Boehringer Ingelheim
NAFLD, NASH, NASH - Nonalcoholic Steatohepatitis, Fibrosis, Liver, Steatosis of Liver
10/25
10/25
Bellanné-Chantelot, Christine
No trials found
Ciangura, Cécile
No trials found
Bleibtreu, Alexandre
No trials found
Mallet, Maxime
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Duval, Xavier
FAVIDOSE, NCT06024421: Evaluation of Tolerance and Pharmacokinetic Profile of High Doses of Favipiravir in Healthy Volunteers

Recruiting
1
39
Europe
favipiravir, Placebo
Institut National de la Santé Et de la Recherche Médicale, France, FUJIFILM Toyama Chemical Co., Ltd.
Infectious Disease, Pharmacology
06/27
11/27
RESPIVAC, NCT05582239: Measure of Vaccine Effectiveness to Prevent Hospitalizations for Viral Respiratory Infections in Adults

Recruiting
N/A
2400
Europe
ANRS, Emerging Infectious Diseases, P95, I-REIVAC, EPICONCEPT, Institut de Recherche en Santé Publique, France
Severe Acute Respiratory Infection (SARI), Influenza, COVID-19
01/26
01/26
Ratziu, Vlad
NATiV3, NCT04849728: A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( )

Recruiting
3
1000
Europe, Canada, US, RoW
IVA337, Lanifibranor, Placebo
Inventiva Pharma
NASH - Nonalcoholic Steatohepatitis
09/25
09/26
B-Well 2, NCT05630820 / 2022-002268-53: Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B

Active, not recruiting
3
871
Europe, Canada, Japan, US, RoW
Bepirovirsen, Placebo
GlaxoSmithKline, GlaxoSmithKline Research & Development Limited
Chronic Hepatitis B, Hepatitis B, Chronic
11/25
05/26
HORIZON, NCT05583344 / 2022-002538-14: Phase 2b Study of GSK4532990 in Adults With NASH

Active, not recruiting
2
284
Europe, Canada, Japan, US, RoW
GSK4532990, Placebo
GlaxoSmithKline, GlaxoSmithKline Research & Development Limited
Nonalcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease
01/26
04/27
M148, NCT06519331: Development of a New Method for Liver Stiffness Measurement Using FibroScan

Not yet recruiting
N/A
114
Europe
Research FibroScan (FS)
Echosens
Liver Diseases
10/26
05/27
DPAILO-1, NCT06344364: Digital Pathology and AI for Liver Outcomes in MASLD

Not yet recruiting
N/A
1800
Europe, RoW
Digital Pathology FibroNest Phenotypic Fibrosis Composite Score (Ph-FCS)
PharmaNest, Inc, Chinese University of Hong Kong, University of Edinburgh, University of Seville, Imperial College London, Icahn School of Medicine at Mount Sinai, Fundacio Clinic Barcelona, Sorbonne University, Newcastle University
Metabolic Dysfunction-associated Steatotic Liver Disease
05/25
07/25
NCT05479721: LITMUS Imaging Study

Active, not recruiting
N/A
450
Europe, US
University of Oxford, Newcastle University, University of Nottingham, University of Cambridge, University of Seville, Pinnacle Clinical Research, PLLC, ICAN Nutrition Education and Research, Assistance Publique - Hôpitaux de Paris, University of Angers, University of Palermo, University of Turin, Italy, University Medical Center Mainz, University of Helsinki, University of Bern, Linkoeping University, Perspectum, Antaros Medical, Resoundant Inc, Pfizer, Novartis, Takeda, Intercept Pharmaceuticals, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Boehringer Ingelheim
NAFLD, NASH, NASH - Nonalcoholic Steatohepatitis, Fibrosis, Liver, Steatosis of Liver
10/25
10/25
Bellanné-Chantelot, Christine
No trials found
Ciangura, Cécile
No trials found
Bleibtreu, Alexandre
No trials found
Mallet, Maxime
No trials found

Download Options